The Top 10 Things Nephrologists Wish Every Primary Care Physician Knew

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2009 Feb 3

PMID 19181652

Citations 15

Authors

Neil M Paige

Glenn T Nagami

Affiliations

Soon will be listed here.

Abstract

Renal disease is commonly encountered by primary care physicians during their day-to-day visits with patients. Common renal disorders include hypertension, proteinuria, kidney stones, and chronic kidney disease. Despite their prevalence, many physicians may be unfamiliar with the diagnosis and initial treatment of these common renal disorders. Early recognition and intervention are important in slowing the progression of chronic kidney disease and preventing its complications. The evidence-based pearls in this article will help primary care physicians avoid common pitfalls in the recognition and treatment of such disorders and guide their decision to refer their patients to a specialist.

Citing Articles

Hemolysis during open heart surgery in patients with hereditary spherocytosis - systematic review of the literature and case study.

Mendrala K, Czober T, Darocha T, Hudziak D, Podsiadlo P, Kosinski S Perioper Med (Lond). 2024; 13(1):54.

PMID: 38858770 PMC: 11163860. DOI: 10.1186/s13741-024-00411-w.

Association Between Buprenorphine Dose and the Urine "Norbuprenorphine" to "Creatinine" Ratio: Revised.

Furo H, Wiegand T, Rani M, Schwartz D, Sullivan R, Elkin P Subst Abuse. 2023; 17:11782218231153748.

PMID: 36937705 PMC: 10014968. DOI: 10.1177/11782218231153748.

High phosphate intake induces bone loss in nephrectomized thalassemic mice.

Wanna-Udom S, Luesiripong C, Sakunrangsit N, Metheepakornchai P, Intharamonthian S, Svasti S PLoS One. 2022; 17(5):e0268732.

PMID: 35622784 PMC: 9140286. DOI: 10.1371/journal.pone.0268732.

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?.

De Nicola L, Cozzolino M, Genovesi S, Gesualdo L, Grandaliano G, Pontremoli R J Nephrol. 2022; 35(6):1605-1618.

PMID: 35583597 PMC: 9300572. DOI: 10.1007/s40620-022-01336-7.

Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry.

Oeun B, Hikoso S, Nakatani D, Mizuno H, Suna S, Kitamura T BMJ Open. 2021; 11(9):e049371.

PMID: 34526341 PMC: 8444246. DOI: 10.1136/bmjopen-2021-049371.

References

Wolf G, Ritz E . Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 2005; 67(3):799-812. DOI: 10.1111/j.1523-1755.2005.00145.x. View

Kannel W, Stampfer M, CASTELLI W, Verter J . The prognostic significance of proteinuria: the Framingham study. Am Heart J. 1984; 108(5):1347-52. DOI: 10.1016/0002-8703(84)90763-4. View

Coburn J, Mischel M, Goodman W, Salusky I . Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis. 1991; 17(6):708-11. DOI: 10.1016/s0272-6386(12)80356-8. View

Burstein D, Korbet S, Schwartz M . Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993; 22(1):5-10. DOI: 10.1016/s0272-6386(12)70160-9. View

Ginsberg J, Chang B, Matarese R, GARELLA S . Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983; 309(25):1543-6. DOI: 10.1056/NEJM198312223092503. View

Wexner S, Beck D, Baron T, Fanelli R, Hyman N, Shen B . A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American.... Gastrointest Endosc. 2006; 63(7):894-909. DOI: 10.1016/j.gie.2006.03.918. View

Alfrey A . Aluminum toxicity in patients with chronic renal failure. Ther Drug Monit. 1993; 15(6):593-7. DOI: 10.1097/00007691-199312000-00025. View

Drueke T . Intestinal absorption of aluminium in renal failure. Nephrol Dial Transplant. 2002; 17 Suppl 2:13-6. DOI: 10.1093/ndt/17.suppl_2.13. View

Brueggemeyer C, Ramirez G . Membranous nephropathy: a concern for malignancy. Am J Kidney Dis. 1987; 9(1):23-6. DOI: 10.1016/s0272-6386(87)80157-9. View

10.

Bakir A, Hryhorczuk D, Ahmed S, Hessl S, LEVY P, Spengler R . Hyperaluminemia in renal failure: the influence of age and citrate intake. Clin Nephrol. 1989; 31(1):40-4. View

11.

Yokel R . The toxicology of aluminum in the brain: a review. Neurotoxicology. 2000; 21(5):813-28. View

12.

Markowitz G, Stokes M, Radhakrishnan J, DAgati V . Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005; 16(11):3389-96. DOI: 10.1681/ASN.2005050496. View

13.

Makkar R, Shen B . What are the caveats to using sodium phosphate agents for bowel preparation?. Cleve Clin J Med. 2008; 75(3):173-6. DOI: 10.3949/ccjm.75.3.173. View

14.

Schwab S, CHRISTENSEN R, Dougherty K, KLAHR S . Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med. 1987; 147(5):943-4. View

15.

Warren G, Korbet S, Schwartz M, Lewis E . Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis. 1989; 13(2):127-30. DOI: 10.1016/s0272-6386(89)80130-1. View

16.

Vukasin P, Weston L, Beart R . Oral Fleet Phospho-Soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Dis Colon Rectum. 1997; 40(4):497-9. DOI: 10.1007/BF02258399. View

17.

Singh A, Szczech L, Tang K, Barnhart H, Sapp S, Wolfson M . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355(20):2085-98. DOI: 10.1056/NEJMoa065485. View

18.

Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

19.

Levin A, Thompson C, Ethier J, Carlisle E, Tobe S, Mendelssohn D . Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999; 34(1):125-34. DOI: 10.1016/s0272-6386(99)70118-6. View

20.

Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T . Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004; 27(3):193-202. DOI: 10.1291/hypres.27.193. View